AS

Amita Shreepatrao Kamde

Active Director Designated Partner DIN 10066701
DIN 10066701 First appointment Mar 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Amita Shreepatrao Kamde

Data last updated:

Amita Shreepatrao Kamde is a Designated Partner at Sagran Healthtech Llp (since 2023).

DIN 10066701
Primary Designation Designated Partner
First Appointment 11 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Mar 20232023Active

Board colleagues of Amita Shreepatrao Kamde

NameDINCompanyDesignation
Ankur Kler10066703Sagran Healthtech LlpDesignated Partner
Asha Dey08374082Sagran Healthtech LlpDesignated Partner
Rakhi Goyal10066702Sagran Healthtech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Sagran Healthtech Llp
Premium access

Shareholding and investment profile for Amita Shreepatrao Kamde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amita Shreepatrao Kamde

Amita Shreepatrao Kamde currently holds 1 directorship: Sagran Healthtech Llp (Designated Partner, since 11 Mar 2023).

Amita Shreepatrao Kamde was first appointed on 11 Mar 2023 as Designated Partner at Sagran Healthtech Llp.

The current boards of Amita Shreepatrao Kamde's companies include Ankur Kler (Sagran Healthtech Llp), Asha Dey (Sagran Healthtech Llp), Rakhi Goyal (Sagran Healthtech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available